Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.), SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.)
Client-Reported Lobbying Expenses
$27.0M
138 filings
Firm Income Reported for This Client
$1.9M
Not substituted for client expenses
Summary
SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.) is an organization, based in MA. Its political footprint includes $27.0 million in client-reported lobbying expenses, $1.9 million in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark. Political activity spans from 2006 to 2024.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 81% YoY
2024: $210K (complete years)
Activity data: Senate LDA